semaglutide and heart palpitations increased heart rate with GLP1 meds # semaglutide #tirzepatide A SHOCKING CASE OF SEMAGLUTIDE-INDUCED

The reporting odds ratio for alopecia was 2.46 (95% CI 2.142.83) for semaglutide and 1.73 (95% CI 1.422.09) for tirzepatide

The cost barrier makes these products unsuitable for a public health approach, which aims to ensure the widest possible access to medicines at the population level and to strike a balance between the best-established standard of care and what is feasible on a large scale in resource-limited settings

NICE guidance recommends regular review of patients taking GLP-1 agonists, typically every 3-6 months, to assess treatment response, side effects, and ongoing appropriateness of therapy

At Foundations at Maitland, our medical staff can help you determine if weight loss injections are appropriate for your individual needs and goals

However, it bears the load of delivering the drug to the patient with cold-chain facilities and often helps them with injecting it through at-home diagnostics visits